Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study

Daisuke Kamimura1, Loretta R Cain2, Robert J Mentz3

  • 1Department of Medicine (D.K., E.R.F., J.B., M.D.W., A.C., M.E.H.).

Circulation
|April 18, 2018
PubMed

Insights

Cigarette smoking significantly impacts heart health, leading to left ventricular (LV) changes and increasing the risk of heart failure (HF) hospitalization in Black adults. This study highlights smoking as a key risk factor for cardiac dysfunction.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cigarette smoking is a known contributor to cardiovascular disease.
  • Previous research suggests links between smoking and cardiac dysfunction.
  • The Jackson Heart Study investigated cardiovascular health in Black adults.

Purpose of the Study:

  • To examine the association between cigarette smoking and left ventricular (LV) structure and function.
  • To investigate the relationship between smoking and brain natriuretic peptide levels.
  • To determine if smoking is associated with incident heart failure (HF) hospitalization.

Main Methods:

  • Analysis of 4129 Black participants from the Jackson Heart Study (never, current, former smokers).
  • Cardiac magnetic resonance imaging used to assess LV structure and function in 1092 participants.
  • Brain natriuretic peptide levels and incident HF hospitalizations analyzed in subgroups.

Main Results:

  • Current smoking linked to increased LV mass index and reduced LV circumferential strain.
  • Smoking status, intensity, and burden correlated with higher brain natriuretic peptide levels.
  • Current smoking, smoking intensity, and smoking burden significantly increased HF hospitalization risk.

Conclusions:

  • Cigarette smoking is a significant risk factor for LV hypertrophy and systolic dysfunction in Black individuals.
  • Smoking independently predicts incident heart failure hospitalization, even after accounting for coronary heart disease.
  • Public health interventions targeting smoking cessation are crucial for cardiovascular health in this population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360